Q4 Season Delivers More Misses: Dixon -36%, Dr Reddy's -86% as WPI Bites
Multiple large-cap names — Dixon Technologies, Dr Reddy's Laboratories, Pfizer India, and Tata Power — all posted Q4 FY26 profit declines, reinforcing that this is not isolated sector weakness. Dixon's 36% PAT crash is particularly notable given its role as India's electronics manufacturing PLI anchor — volumes may be strong but margin compression at the input cost level is severe, and ICRA's CNBC TV18 warning that April WPI hit 8.3% (vs ICRA's 5% estimate) confirms the cost-push pressure will persist for months. Watch for a sector-wide FY27 guidance revision in the coming weeks as managements digest fuel-driven input inflation.
Read full story →